Bernd Salzberger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Bernd Salzberger has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Helmut Uphoff
Geschäftsstelle Klimaanpassung, Hessisches Landesprüfungs- und Untersuchungsamt im Gesundheitswesen (HLPUG) – Abteilung 1 Infektionsepidemiologie, Wolframstr. 33, 35683 Dillenburg
1 shared publication - Johannes Hain
GSK, Munich, Germany
1 shared publication - Markus Knuf
Klinikum der Landeshauptstadt Wiesbaden, Klinik für Kinder und Jugendliche
1 shared publication - Markus Schwehm
Explosys
1 shared publication - Martin Eichner
Department of Medical Biometry, University of Tübingen, Tübingen, Germany
1 shared publication - Ruprecht Schmidt-Ott
GlaxoSmithKline Vaccines, Wavre, Belgium
1 shared publication
Latest Publications
- Open Access
- 3 July 2014
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 14 (1) , 365
4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany
Influenza vaccines contain Influenza A and B antigens and are adjusted annually to match the characteristics of circulating viruses. In Germany, Influenza B viruses belonged to the B/Yamagata lineage, but since 2001, the antigenically distinct B/Victoria lineage has been co-circulating. Trivalent influenza vaccines (TIV) contain antigens of the two A subtypes A(H3N2) and A(H1N1), yet of only one B lineage, resulting in frequent vaccine mismatches. Since 2012, the WHO has been recommending vaccine strains from both B lineages, paving the way for quadrivalent influenza vaccines (QIV).
- 3 July 2014
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 14 (1) , 365
Open Access4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany
Influenza vaccines contain Influenza A and B antigens and are adjusted annually to match the characteristics of circulating viruses. In Germany, Influenza B viruses belonged to the B/Yamagata lineage, but since 2001, the antigenically distinct B/Victoria lineage has been co-circulating. Trivalent influenza vaccines (TIV) contain antigens of the two A subtypes A(H3N2) and A(H1N1), yet of only one B lineage, resulting in frequent vaccine mismatches. Since 2012, the WHO has been recommending vaccine strains from both B lineages, paving the way for quadrivalent influenza vaccines (QIV).